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 T Cell Receptor Ligand-Specific
Oligomerization Revisited
a signaling mechanism is conceptually appealing, as
there are many receptors for which it has been sug-
gested that signaling proceeds through ligand-induced
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receptor oligomerization (Klemm et al., 1998), although2 Howard Hughes Medical Institute
evidence is accumulating that some of these receptors7 Divinity Avenue
exist as preformed oligomers prior to ligation (Livnah etCambridge, Massachusetts 02138
al., 1999; Schamel and Reth, 2000). Initial support for
ligand-induced TCR oligomerization came from the ob-
servation of a dimer in the crystal structure of the classSummary
II MHC HLA-DR1 (Brown et al., 1993), but this was offset
by the subsequent discovery of different dimeric ar-The mechanism of T cell receptor signaling is unclear.
rangements in other class II MHC crystals (e.g., FremontIncluded among models for TCR signaling is ligand-
et al., 1996). A subsequent “kinetic proofreading” modelinduced oligomerization in a fashion analogous to
of TCR signal transduction proposed that specificity inother cell surface receptors. Published kinetic, satura-
the T cell response could be achieved through timetion binding, and light scattering experiments have
delays that included assembly of TCR/peptide/MHCbeen interpreted to suggest a propensity for soluble
oligomers (McKeithan, 1995). Clustering of TCR/pep-TCR/peptide/MHC ectodomain complexes to oligo-
tide/MHC complexes has been observed (Monks et al.,merize. Upon performing these experiments with solu-
1998), although it is unknown whether such clustersble ectodomains of human class I and class II re-
reflect the specific oligomerization of TCR/peptide/MHCstricted TCRs, we find no evidence for dimerization
complexes and whether clustering is an initial eventor oligomerization of complexes. Apparently, oligo-
leading to signaling or a later event resulting after initialmerization in solution to a detectable extent is not a
signaling. Despite the observation of dimers in the HLA-general property of soluble TCRs or their com-
DR1 crystal structure, no dimers have been observedplexes with ligand. Our results suggest that mem-
in the more than half-dozen X-ray structures of TCR/brane-anchored, fully assembled TCRs should be
peptide/MHC complexes (Hennecke et al., 2000; De-studied to determine the role oligomerization plays in
gano et al., 2000; Ding et al., 1998, 1999; Garboczi etT cell signaling.
al., 1996a; Garcia et al., 1998; Reinherz et al., 1999;
Reiser et al., 2000; Teng et al., 1998). Soluble oligomericIntroduction
peptide/MHC complexes have been shown to activate
T cells more effectively than monomers (Boniface et al.,Signal transduction through the membrane-bound T cell
1998; Cochran et al., 2000), yet these experiments doreceptor (TCR) complex (composed of an TCR, CD3,
not discriminate among different signaling mechanismsand  polypeptides) is necessary for the development
that involve simultaneous ligation of multiple TCRs.of the T cell repertoire and the initiation of a cellular
Direct evidence for oligomerization of soluble TCR/immune response. Despite advances in understanding
peptide/MHC complexes in solution comes from twohow the T cell signal is propagated within the cell (e.g.,
reports. In the first, light scattering was used to showGermain and Stefanova, 1999), few details are known
that populations of different sizes arise as the mouseof the mechanism by which engagement of a TCR by
TCR 2B4 is mixed with an agonist ligand at 21C (theits ligand, a cell surface peptide/MHC complex, results
moth cytochrome C peptide presented by the class II
in signaling. A number of models have been proposed;
MHC Ek [MCC/Ek]) at concentrations above the KD of thethese include conformational changes occurring within
TCR-peptide/MHC interaction (Reich et al., 1997). This
a single TCR heterodimer (e.g., Janeway, 1995), geomet- effect was interpreted as assembly of TCR/peptide/
rical rearrangements within a multivalent TCR/CD3 com- MHC complexes into oligomers. In the second report,
plex (e.g., Ding et al., 1999), segregation of kinase and surface plasmon resonance (Biacore) was used to show
phosphatases due to varying sizes of extracellular do- that at 37C (but not 25C) the kinetics of the mouse
mains (e.g., van der Merwe et al., 2000; Shaw and Dustin, TCR OT-1 binding to an agonist ligand (the ovalbumin
1997; Davis and van der Merwe, 1996), and oligomeriza- peptide presented by the class I MHC Kb [OVA/Kb]) devi-
tion of TCR/peptide/MHC complexes (e.g., Brown et al., ate from simple 1:1 binding (Alam et al., 1999). The devia-
1993; Bachmann and Ohashi, 1999), where oligomeriza- tions were consistent with a TCR “dimerization” model,
tion is distinguished from more general “clustering” as in which a second TCR binds to an TCR/peptide/
being driven by an affinity of one TCR/peptide/MHC MHC complex. A second experiment was used to sup-
complex for another. In each model, the molecular event port this interpretation, where under steady state condi-
(i.e., conformational change, geometrical rearrangement, tions the response at 37C was close to twice that ob-
segregation, or oligomerization) is presumed to alter the served at 25C.
degree of phosphorylation on the cytoplasmic side of Here, we have replicated both the previously pub-
the membrane in favor of signal transduction. lished light scattering and surface plasmon resonance
Oligomerization of TCR/peptide/MHC complexes as experiments (Reich et al., 1997; Alam et al., 1999) using
human TCR and peptide/MHC molecules. We have
also performed sedimentation equilibrium analytical ul-3 Correspondence: dcwadmin@crystal.harvard.edu
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Figure 1. Kinetic Biacore Data at 25C for the A6 TCR Binding Tax/HLA-A2 and Tax-P6EtG/HLA-A2
(A) Raw data over the protein-coupled (black line) and mock (red line) flowcells. Tax/HLA-A2 was coupled to 1000 RU and Tax/P6EtG to
1700 RU. Injected TCR concentrations were 5.35 M, 2.52 M, and 880 nM for the Tax/HLA-A2 surface and 4.53 M, 3.02 M, and 1.51
M for the Tax-P6EtG/HLA-A2 surface.
(B) Binding response in (A) corrected for the response from the mock flowcell (black line) along with a fit to a 1:1 binding model (red line).
Residuals for the fitted portions of the curves are indicated below the plot. Fitted parameters are given in Table 1A.
tracentrifugation at 37C to complement our previous Results
centrifuge studies at 25C. We have studied the human
TCR A6 specific for the Tax peptide presented by Kinetic Biacore Experiments at 25C and 37C Are
Both Described by a Simple 1:1 Binding Modelthe class I MHC HLA-A2 and the human TCR HA1.7
specific for the HA peptide presented by the class II Surface plasmon resonance (Biacore) has been used to
show that at 37C (but not at 25C) the kinetics of theMHC HLA-DR4. The binding of the A6 TCR to HLA-A2
complexed with a number of Tax-derived peptides has mouse TCR OT-1 binding to the agonist ligand OVA/
Kb deviate from simple 1:1 binding (Alam et al., 1999).been characterized structurally, thermodynamically,
and kinetically (Baker et al., 2000a, 2000b; Ding et al., These deviations were only observed when the peptide/
MHC was attached to the Biacore sensor chip, not when1999; Garboczi et al., 1996a). The HA1.7/HA/HLA-DR4
complex, whose structure has recently been deter- the TCR was attached. Our previous Biacore investiga-
tions of the interaction of the A6 TCR with the classmined, is covalently stabilized (Hennecke et al., 2000),
overcoming the primary limitation of experiments de- I MHC HLA-A2 bound with Tax-based peptides, which
were all well described by a 1:1 binding model, weresigned to detect TCR/peptide/MHC oligomers; that
is, the relatively weak affinity of the TCR for its ligand. performed with the TCR attached to the sensor chip
(Baker et al., 2000a, 2000b; Ding et al., 1999). To replicateNone of the experiments we have performed provides
evidence for oligomerization of TCR/peptide/MHC the earlier experiments in which complex binding kinet-
ics were observed (Alam et al., 1999), we attached thecomplexes. Apparently, oligomerization to a detectable
extent in solution is not a general property of soluble peptide/MHC to the sensor chip using amine crosslink-
ing. Figure 1A shows kinetic datasets at 25C for injec-TCR/peptide/MHC ectodomain complexes. Our re-
sults suggest that membrane-anchored, fully assembled tions of the A6 TCR over two surfaces: HLA-A2 loaded
with wild-type Tax peptide (an agonist; sequenceTCRs (i.e., including TCR, CD3, and  polypeptides)
should be studied to determine the potential role for LLFGYPVYV) and HLA-A2 with Tax-P6EtG (Tax with pro-
line 6 substituted with N-ethyl glycine, a more potentoligomerization in T cell signaling.
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Table 1. Parameters for the A6 TCR Binding HLA-A2 with Tax Variants
A. Kinetic Measurementsa
Tax Peptide Temperature kon (M1 s1) koff (s1) t1/2 (s)b koff/kon (M)
WT
25C 6.21  0.05  104 (1.1  105) 0.081  0.001 (0.093) 8.56  0.11 (7.5) 1.35  0.02 (0.91)
37C 8.44  0.21  104 0.201  0.003 3.45  0.05 2.38  0.08
P6EtG
25C 7.80  0.15  104 (6.6  104) 0.242  0.003 (0.23) 2.86  0.04 (3.0) 3.10  0.07 (3.50)
37C 1.10  0.07  105 0.573  0.017 1.21  0.04 5.21  0.16
B. Steady State Measurements
Tax Peptide Temperature KD (M) RUmax Saturation at Highest Injected Concentration
WT
25C 1.86  0.06 210  2 98%
37C 3.57  0.20 213  3 96%
P6EtG
25C 3.65  0.16 256  3 92%
37C 4.64  0.21 255  4 90%
a Numbers in parentheses are previous determinations with the reverse orientation, i.e., the TCR tethered to the sensor chip (Baker et al.,
2000b; Ding et al., 1999).
b t1/2 	 0.693/koff.
agonist than wild-type; Baker et al., 2000b). Shown with counted for. The kinetic parameters from the fits are
given in Table 1A. For HLA-A2 coupled with both pep-the binding data are data from injections over mock
surfaces with no coupled protein. Figure 1B shows the tides, at 37C both association and dissociation rates
increase, resulting in TCR affinities slightly weaker andbinding responses with the data from the mock surfaces
subtracted; also shown are fits to a 1:1 binding model. TCR/peptide/MHC complex half-lives shorter than those
observed at 25C.Inspection of the fits and examination of the residuals
reveals that the interactions are well described by this Complex association and dissociation kinetics were
observed when the OT-1 TCR bound OVA/Kb at 37Csimple model. The fitted parameters are presented in
Table 1A, and all are in good agreement with the values (Alam et al., 1999). This was interpreted as TCR “dimer-
ization,” i.e., the binding of a second TCR to anfrom our previous investigations where the TCR was
coupled to the chip (values also in Table 1A; Baker et TCR/peptide/MHC complex already present on the
chip. As no association of ligand-free TCR was reported,al., 2000b; Ding et al., 1999). The quality of the fits and
the agreement between the parameters regardless of the putative association of TCR to TCR/peptide/MHC
complexes might occur through a conformationalwhich molecule is tethered to the chip suggest that
orientational heterogeneity resulting from the amine link- change in a bound TCR such that it would be recognized
by an incoming unbound TCR, or by the generationage does not complicate this experiment.
Figure 2A shows injections over the same surfaces of an interaction surface composed of TCR and MHC
components recognizable by a free TCR. However,as in Figure 1, but with the temperature at 37C. Again,
the data for each protein-coupled flowcell are presented these authors did not account for injections over a mock
surface. An alternative interpretation of the complex ki-along with data from the mock flowcell. As opposed to
the 25C data (Figure 1A), there is a large amount of netic data attributed to TCR dimerization (Alam et al.,
1999) may be that the second binding event representsupward nonlinear drift during the association phases.
This is followed by downward nonlinear drift after the a similar form of drift as shown in Figure 2. Indeed, a
small amount of drift is visible when the OT-1 TCR wasinitial decay of the dissociation phases. These patterns
of drift are similar to those observed when the OT-1 injected over an OT-1 sensor surface at 37C (see Figure
2E in Alam et al. [1999]).TCR bound OVA/Kb at 37C (Alam et al., 1999). Note,
however, that in Figure 2A the drift is also present in If uncorrected drift due to association of the TCR
with the sensor surface is responsible for complex TCRthe mock injections. There is thus some association of
the TCR with the surface of the sensor chip at 37C. binding kinetics observed at 37C (Alam et al.,1999), a
pertinent question is why it is not observed with antago-Figure 2B shows an attempt to fit the 37C data un-
corrected for the bulk refractive index shift and drift nist or null peptide/MHC molecules coupled to the sen-
sor surface (i.e., Figure 6 in Alam et al. [1999]). It isto a simple 1:1 binding model. It is apparent that this
model does not describe the data well. However, when possible that the binding kinetics at 37C for these li-
gands are slower such that when coupled with thethe data from the mock surfaces are subtracted from
the binding data, shown in Figure 2C, the data are fit weaker TCR affinities for these ligands, the summation
of the responses from TCR binding and drift does notwell by a 1:1 binding model. There is therefore no need
to incorporate terms describing additional molecular produce such dramatic deviations from a 1:1 fit as is
observed with higher affinity agonist ligands.events (i.e., second-site binding, conformational changes,
dimerization, etc.) into the fitting function at 37C, pro- The Tax-P6EtG peptide is a more potent agonist than
the wild-type Tax peptide (Baker et al., 2000b). Despitevided the bulk refractive index shift and drift are ac-
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Figure 2. Kinetic Biacore Data at 37C for the A6 TCR Binding Tax/HLA-A2 and Tax-P6EtG/HLA-A2
(A) Raw data over the protein-coupled (black line) and mock (red line) flowcells. Surfaces and injected concentrations are the same as used
in Figure 1.
(B) 1:1 fits to the binding response in (A) uncorrected for the response from the mock flowcell. Residuals for the fitted portions of the curve
are indicated below the plot.
(C) Binding response in (A) corrected for the response from the mock flowcell (black line) along with a fit to a 1:1 binding model (red line).
Residuals for the fitted portions of the curves are indicated below the plot. Fitted parameters are given in Table 1A.
this, our previous investigations showed that relative Identical Dissociation Kinetics as a Function
of Surface Density Argue against Oligomerizationto the wild-type peptide, at 25C Tax-P6EtG results in
slightly weaker TCR binding and a shorter half-life of of TCR/Peptide/MHC Complexes at 37C
If a second TCR bound to a TCR/peptide/MHC complex,the TCR/peptide/MHC complex (Baker et al., 2000b).
These measurements are confirmed here; furthermore, seemingly it would be able to bind a second peptide/
MHC to form a [TCR/peptide/MHC]2 “superdimer.” De-the same trend is observed at 37C. As we concluded
in our previous report, for the Tax-P6EtG peptide there pending on the oligomerization model, further lateral
association could occur. With the peptide/MHC teth-is no correlation of cytotoxic potency withTCR affinity
or the half-life of the TCR/peptide/MHC complex. ered, whether or not this occurs on a Biacore surface
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from the response from a peptide/MHC surface (data
from two repeated injections are shown). Fits to a 1:1
binding model are shown along with the data points;
fitted parameters are the KD and the maximum binding
capacity (RUmax) of the surface. Note that all the fitted
curves approach saturation at the highest injected con-
centration; that is, nearly every peptide/MHC available
is bound by a TCR. Figure 4C shows representative
injections at 25C and 37C for which steady state equi-
librium was achieved.
The fitted parameters from the fits in Figures 4A and
4B are given in Table 1B. Comparison of the KD values
with those in Table 1A reveals good agreement with
those determined kinetically (e.g., 1.86 M versus 1.35
M for the interaction with Tax/HLA-A2 at 25C). The
fitted maximum binding capacities (RUmax, the response
that would be obtained by complete saturation) of each
surface at 25C and 37C are also given in Table 1B.Figure 3. Biacore Dissociation Phases at 37C for the A6 TCR Bind-
Importantly, for the A6 TCR binding both Tax/HLA-A2ing Tax/HLA-A2 Coupled to Either High-Density (6500 RU) or Low-
and Tax-P6EtG/HLA-A2, the values of RUmax are theDensity (1000 RU)
same within error regardless of temperature (this is alsoFitting of the data (circles) to a single exponential decay (solid lines)
yields the same dissociation rate (0.21 s1) regardless of coupling apparent from the maximum of the fitted curves in Figure
density. 4). If additional TCR molecules were binding at 37C,
this would be apparent as a higher maximum response,
which we do not observe (note the maximum response
would depend on the mobility of the dextran layer and differs from the peptide/MHC immobilization RU, given
the density of coupled protein. Interactions between in Figure 4 legend, a frequent occurrence (e.g., Myszka
proteins on Biacore sensor chips can be observed and et al., 1996) attributable to differences in protein size
quantified; for example, the IL-2 receptor  and  sub- and coupled protein inaccessibility or inactivity).
units were shown to exist in a preassembled form by An 2-fold greater steady state equilibrium response
studying the binding of IL-2 to sensor chips with both was observed when the OT-1 TCR bound OVA/Kb at
subunits coupled to the same chip at varying densities 37C compared to 25C, which was interpreted as the
(Myszka et al., 1996). Thus, constrained mobility within binding of a second TCR to a TCR/peptide/MHC com-
the dextran layer should not prevent a TCR bound to a plex at 37C (Alam et al., 1999). Such “dimerization” can
TCR/peptide/MHC complex binding a second peptide/ be demonstrated by showing an increase in the RUmax
MHC. of a sensor surface with temperature, either through
If a second TCR bound to a TCR/peptide/MHC com- injection of a concentration known to fully saturate the
plex was still competent to bind ligand, as the peptide/ chip at 25C, which gives a higher response at 37C,
MHC density increased on the sensor chip the observed or preferably by determination of RUmax by a complete
equilibrium binding experiment that approaches satura-binding kinetics should change as a second peptide/
tion at both temperatures. With a KD at 25C for the OT-MHC is bound; at the very least the observed dissocia-
1-OVA/Kb interaction of 5.9 M, the injected concentra-tion rate would decrease due to the positive cooperativ-
tion of OT-1 used to demonstrate additional binding atity resulting from the additional interfaces. Figure 3
37C (9 M; Alam et al., 1999) would have saturated theshows dissociation phases at 37C for the A6 TCR bind-
sensor surface to only 60% at 25C (Figures 4C anding to Tax/HLA-A2 coupled to two different surface den-
4D in Alam et al. [1999]; see Equation 1 in Experimentalsities (6400 RU and 1000 RU) along with fits to a
Procedures).first order exponential decay (data are corrected for the
An alternative interpretation, not requiring dimeriza-injections over mock surfaces as above). Both surfaces
tion, of the steady state experiments with the OT-1 TCRyield a dissociation rate of 0.21 s1, nearly identical to
(Alam et al., 1999) would be that the affinity of the OT-1the value obtained by analysis of a complete dataset
TCR for OVA/Kb becomes stronger over the temperature(0.20 s1; Table 1A). This provides another indication
range studied, so more TCR binds available peptide/that a second A6 TCR does not bind an A6/Tax/HLA-
MHC on the sensor surface (this is in contrast to whatA2 complex at 37C.
we have observed here, in which the affinity of the A6
TCR for Tax/HLA-A2 and Tax-P6EtG/HLA-A2 weakens
Equilibrium Biacore Experiments Indicate Identical with temperature). This would explain the increased re-
Stoichiometries at 25C and 37C sponse observed at 37C when the sensor chip was not
Figure 4 shows the results of steady state equilibrium saturated. Increases in binding affinity with temperature
experiments at 25C (Figure 4A) and 37C (Figure 4B) are not uncommon; some well-characterized examples
for the A6 TCR binding HLA-A2 loaded with wild-type are the binding of the 
 Cro repressor to DNA (Takeda
Tax and Tax-P6EtG. The same surfaces were used for et al., 1992) and tubulin self-association (Vulevic and
both temperatures. Each data point represents the Correia, 1997).
steady state equilibrium response obtained from the The temperature dependence of the equilibrium con-
stant, given by the van’t Hoff equation, is dependentinjection of the TCR over a mock surface subtracted
Immunity
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Figure 4. Steady State Equilibrium Biacore Data at 25C and 37C for the A6 TCR Binding Tax/HLA-A2 and Tax-P6EtG/HLA-A2
(A) Steady state equilibrium responses versus injected A6 TCR concentration at 25C. Coupling was 6400 RU for Tax/HLA-A2 and 6500
RU for Tax/P6EtG. Fits to a 1:1 binding model are indicated along with the data. Fitted parameters are in Table 1B.
(B) Steady state equilibrium responses versus injected A6 TCR concentration at 37C obtained from the same surfaces as in (A). Fits to a 1:1
binding model are indicated along with the data. Fitted parameters are in Table 1B.
(C) Representative injections for which steady state equilibrium was reached. Injected concentrations of A6 TCR were 88 M (Tax/HLA-2
surface) and 40 M (Tax-P6EtG/HLA-A2 surface).
upon the enthalpy (H) change for the reaction. En- that the mouse 2C TCR binds the mouse class I MHC
Ld with the QL9 peptide with a tighter affinity at 37C thanthalpy changes for binding reactions can be endother-
mic (positive and unfavorable) or exothermic (negative at 4C. Furthermore, single amino acid substitutions in
the peptide altered the temperature dependence:and favorable). For an endothermic (i.e., entropically
driven) reaction, affinity will become stronger with tem- changing Phe5 to Gln, His, or Arg resulted in weaker
TCR binding affinity at 37C, whereas changing Phe5 toperature (note, though, that protein binding reactions
are usually accompanied by negative heat capacity Tyr left the wild-type temperature dependence intact
(note that TCR dimerization detectable at 37C but notchanges, which will impart curvature into the tempera-
ture dependence of the equilibrium constant). The sign 25C would require an endothermic, entropically driven
reaction).and magnitude of the enthalpic contribution to binding
will be determined by the molecular details of the binding
reaction, e.g., the numbers and types of hydrogen bonds Sedimentation Equilibrium Analytical Ultracentrifugation
Provides No Evidence for Oligomerizationand salt bridges formed, changes in solvent accessible
hydrophobic surface area, buried water, etc. (e.g., Ross of TCR/Peptide/MHC Complexes
We recently used sedimentation analytical ultracentrifu-and Subramanian, 1981). Possibly important here are
the results of Schlueter et al. (1996), who demonstrated gation to characterize the interaction of the A6 TCR
TCR Ligand-Specific Oligomerization Revisited
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Figure 5. Sedimentation Equilibrium Analytical Ultracentrifugation Data
(A) Data for 8.5 M A6 TCR  9.2 M Tax/HLA-A2 at 25C centrifuged at 15,000 rpm taken from our previous work (Baker et al., 2000b). Solid
line is a fit to a 1:1 binding model. The contributions to the total absorbance from the complex, free TCR, and free peptide/MHC are indicated.
Residuals are shown beneath the data. Fitted KD is 1.1  0.1 M.
(B) Data for 5.4 M A6 TCR  7.4 M Tax/HLA-A2 at 37C centrifuged at 15,000 rpm. Representation is as in (A). Fitted KD is 1.8  0.2 M.
(C and D) Data for 13 M of the HA1.7/HA/HLA-DR4 complex at 25C (C) and 37C (D). The data at both temperatures are adequately described
as a single ideal species (solid line).
with HLA-A2 complexed with a number of Tax-based One of the difficulties in looking for TCR/peptide/MHC
oligomerization is the relatively weak affinity the TCR haspeptides (Baker et al., 2000b). Sedimentation equilib-
rium is commonly used to examine protein oligomeric for its ligand. With an affinity of1 M, when equimolar
amounts of the A6 TCR and Tax/HLA-A2 are mixed atstates and is well suited for investigating very weak
equilibria. For example, analysis of the pH dependence a total concentration of 18 M (e.g., Figure 5A), the
concentration of TCR/peptide/MHC complex is onlyof -chymotrypsin dimerization by this technique re-
vealed KD values in the millimolar range (Aune and Ti- 13 M (13-fold above the KD). This places a limit on
the magnitude of a self-association equilibrium constantmasheff, 1971). In our recent ultracentrifuge analysis of
the A6 TCR interacting with Tax/HLA-A2, we measured that would produce quantifiable deviations from a 1:1
fit, which under the conditions used here we estimateat 25C a KD of 1.1  0.1 M (Baker et al., 2000b), in
agreement with the value of1M measured by Biacore to be in the range of 200–300 M. To overcome this
limitation, we examined the covalently stabilized com-(Tables 1 and 2; also Ding et al., 1999). Although associa-
tion of the TCR with peptide/MHC could be observed plex of the TCR HA1.7, HA peptide, and class II MHC
HLA-DR4. In this complex, the TCR is covalentlyand quantified (Figure 5A; data from Baker et al., 2000b),
we did not detect any TCR/peptide/MHC oligomeriza- attached through an octapeptide linker to the HA pep-
tide (PKYVKQNTLKLAT). The crystallographic structuretion. Here, we have performed this same experiment at
37C; data for the highest concentration used (13 M) of this complex has recently been determined (J. Hen-
necke and D. C. W., unpublished data) as has the struc-are shown in Figure 5B. Again, although the TCR-pep-
tide/MHC interaction can be measured (KD 	 1.8  0.2 ture of a similarly stabilized HA1.7/HA/HLA-DR1 com-
plex (Hennecke et al., 2000). In both cases, all evidenceM), we do not observe any TCR/peptide/MHC oligo-
merization, which would be apparent as a characteristic suggests that the linker places no restrictions on the
TCR binding mode (Hennecke et al., 2000). The HA1.7/deviation in the pattern of the residuals indicating the
need to account for higher molecular weight species. HA/HLA-DR4 complex is extremely stable, showing no
Immunity
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tendency to dissociate during SDS-PAGE (provided the
samples are not boiled). We estimate the KD for this
complex to be sub-nanomolar (Sato et al., 2000; Seth
et al., 1994). Figures 5C and 5D show sedimentation
equilibrium analytical ultracentrifugation at 25C and
37C for a 13 M sample of this complex. The data
at both temperatures are well described by a model
indicating the presence of a single species. Thus, this
experiment, in which the complex was analyzed at con-
centrations orders of magnitude above the KD, provides
no evidence for TCR/peptide/MHC oligomerization at
either 25C or 37C (we estimate under these conditions
the weakest KD for dimerization we could detect for this
complex would be in the range of 0.5–1 mM). The fitted
molecular weight from this experiment is 94.1 6.3 kDa,
close to the calculated value of 96.7 kDa.
Figure 6. Dynamic Light Scattering Results for 25 M A6 TCR  25
Dynamic Light Scattering Provides No Evidence for M Tax/HLA-A2, 50 M A6 TCR  50 M Tax/HLA-A2, and 77 M
Oligomerization of TCR/Peptide/MHC Complexes of the HA1.7/HA/HLA-DR4 Complex
Dynamic light scattering (also referred to as quasi-elas- Data are from regularization analysis of at least 20 separate mea-
surements. Hydrodynamic radii are indicated on the plot.tic light scattering or photon-correlation spectroscopy)
is ideal for detecting size heterogeneity in protein sam-
ples. The amount of scattered light is proportional to
the size of the species and its concentration. In a light not resolved into a separate peak as it is smaller in
size and scatters less light than the TCR/peptide/MHCscattering experiment, the intensity of scattered light as
a function of time is described by an autocorrelation complex.
The results in Figure 6 are strikingly different fromfunction, the analysis of which yields the hydrodynamic
radii (Rh) of the scattering particles. Light scattering is those observed with the 2B4  TCR (Reich et al., 1997).
The simplest explanation for the difference is thatuseful here as it can detect large particles at very low
concentrations. This provides greater sensitivity than whereas the 2B4/MCC/Ek complex oligomerizes, the A6/
Tax/HLA-A2 and HA1.7/HA/HLA-DR4 complexes stud-analytical ultracentrifugation, although with light scat-
tering molecular weight and concentration distributions ied here do not. However, other interpretations are pos-
sible (the experiments were performed at similar temper-are more difficult to analyze quantitatively.
In light scattering experiments with the mouse  atures, 19 versus 21C). If the multiple peaks observed
upon analysis of the 2B4/MCC/Ek complex indeed repre-TCR 2B4 and class II MHC I-Ek bound with the moth
cytochrome C peptide (MCC/ Ek), two peaks were ob- sent TCR/peptide/MHC oligomers, then the oligomeriza-
tion process must be highly cooperative, as the oligomersserved when the proteins were mixed at high concentra-
tions (Reich et al., 1997). The effect was most observable rise from undetectable levels to a significant component
of the sample with only a7 M increase in the popula-at a total protein concentration of 114 M, approxi-
mately twice the KD for the 2B4 TCR-MCC/Ek interaction tion of TCR/peptide/MHC complexes (Figure 2 in Reich
et al. [1997]; from 13.4 to 20.5M 2B4/MCC/Ek complexes,(Figure 2 in Reich et al. [1997]). The second peak was
interpreted as resulting from TCR/peptide/MHC dimers using 86 and 114 M total protein concentrations and a
KD of 65 M for the 2B4 TCR-MCC/Ek interaction). Itor other oligomers.
Figure 6 shows dynamic light scattering experiments is surprising that the influence of this process has not
been detected in other investigations in the same sys-for the two systems we have investigated here. Data
are shown for three samples: 25 M A6 TCR  25 M tem even when performed at low concentrations (e.g.,
Boniface et al., 1999). Nevertheless, it is clear that theTax/HLA-A2, 50 M A6 TCR  50 M Tax/HLA-A2, and
77 M of the HA1.7/HA/HLA-DR4 complex. All three complexes we have studied here do not behave as the
2B4/MCC/Ek complex, even at concentrations 100-foldsamples are characterized by a single peak. The A6/
Tax/HLA-A2 sample at 50M total protein concentration above the KD for the A6 TCR complex and  10,000-
fold above the estimated KD for the HA1.7 TCR complex.yields an intensity weighted Rh value of 5.4  0.3 nm,
at 100 M the Rh is 5.6  0.4 nm. This is similar to the Other than the species of origin (mouse versus hu-
man), are there differences in the TCR molecules usedvalue of 5.5  0.5 nm reported for the 2B4/MCC/Ek
complex (Reich et al., 1997). The Rh for the HA1.7/HA/ here and by others that could contribute to the different
experimental results we have observed? The A6 TCRHLA-DR4 complex is a smaller 4.6  0.2 nm. This is
expected as the HA1.7 TCR is smaller and less elon- used here has a 37 residue coiled coil attached to the
 and  chains following the membrane-proximal in-gated than the A6 TCR (see Experimental Procedures).
The width of the distributions and standard errors for terchain disulfide. The  and  chains of the HA1.7 TCR
terminate 3 amino acids after the interchain disulfide.the complexes with the A6 TCR are larger than those
for the HA1.7 complex. This can be attributed to the The  and  chains of the 2B4 TCR used in Reich et
al. (1997) include the 5 TCR amino acids following thepresence of uncomplexed protein, which represents
18% and 13% of the total protein in the 50 M and 100 interchain disulfide bond, followed by a small portion of
a GPI-signal sequence and a glycan-inositol linkage leftM samples, respectively. Uncomplexed protein is likely
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after cleavage from a GPI anchor. The OT-1 TCR studied which the data were likewise best described by a 1:1
binding model (e.g., Boniface et al., 1999; Willcox et al.,by surface plasmon resonance (Alam et al., 1999) was
1999). Furthermore, in steady state equilibrium experi-also truncated near the interchain disulfide (Alam et al.,
ments, sensor surfaces were found to saturate at the1996). Thus, each of these TCRs are missing the most
same level regardless of temperature, clearly showingmembrane-proximal regions of the  and  constant
that no additional TCRs are binding to TCR/pep-domains. It is doubtful that the differences at the C-ter-
tide/MHC complexes on the sensor surface. Our calcula-minal ends of these molecules contribute to the differ-
tions indicate that the earlier binding experiments onences we have observed. The HA1.7/HA/HLA-DR4 com-
the murine TCR were not done under saturating con-plex has a disordered 8 amino acid linker attaching the
ditions (Alam et al., 1999).TCR to the peptide, and it is conceivable that this could
Dynamic light scattering has been reported to showinterfere with oligomerization, but this seems unlikely
that two populations of different sizes arise when thegiven that no oligomeric propensity was observed with
murine TCR 2B4 is mixed with MCC/Ek at concentra-A6, which lacks such a linker.
tions 2-fold higher than the KD for the TCR-peptide/Glycosylation states differ among the molecules un-
MHC interaction (Reich et al., 1997). Because light scat-der discussion, although none have the native glycosyla-
tering does not give direct information about the geome-tion found in the mouse or human. In the present work,
try of the interaction, the experiment did not distinguishthe bacterially expressed A6 and HA1.7  TCRs and
between aggregation that is consistent with anchoringHLA-A2 are not glycosylated, whereas HLA-DR4, pro-
into a membrane and other nonphysiological orien-duced in Schneider insect cells, is. In the murine light
tations within aggregates. Furthermore, aggregationscattering study (Reich et al., 1997), both the TCR and
might be observed in some TCR/peptide/MHC com-MHC were produced in mammalian (CHO) cells, and are
plexes simply as a reflection of the difference in solubilitythus glycosylated. It is conceivable then that differences
of the complex relative to the separate, monomeric pro-in glycosylation states could contribute to the differ-
teins. The control, which reported that noninteractingences between our results and those of Reich et al.
pairs of TCR and peptide/MHC showed no aggrega-(1997). In the murine Biacore study (Alam et al., 1999),
tion, might then have reflected the fact that by not form-TCR was used that was produced in both insect and
ing complexes the molecules would not change solu-bacterial systems, whereas the MHC was produced only
bility (Reich et al., 1997). Upon performing thesein bacteria. Thus, glycosylation cannot account for the
experiments with both the A6/Tax/HLA-A2 complex anddifferences observed between our work and that of Alam
the HA1.7/HA/HLA-DR4 complex, we observed only oneet al. (1999).
species in the light scattering response even at concen-
trations orders of magnitude above the KD for the TCR-Discussion
peptide/MHC interactions. Furthermore, sedimentation
equilibrium analytical ultracentrifugation with both theThe mechanism of initiation of TCR signaling, or how
A6 TCR and HA1.7 TCR systems provided no evi-the cytoplasm of a T cell knows when a T cell receptor
dence for dimers or higher-order oligomers of either
has been engaged by peptide/MHC, is unclear. Of the
TCR/peptide/MHC complex.
various models that have been suggested, dimerization
We have suggested alternative explanations for the
or oligomerization of TCR/peptide/MHC complexes re-
earlier Biacore with the OT-1 TCR (Alam et al., 1999).
mains popular, either as a signaling mechanism in itself The altered kinetics at 37C may arise from interactions
(Bachmann and Ohashi, 1999) or as a component of with the Biacore sensor surface in a manner similar to
other proposed mechanisms (van der Merwe et al., that which we have observed here. The increased bind-
2000). However, there is little direct experimental data ing response at 37C may result from a higher affinity
indicating an oligomeric propensity for TCR/peptide/ at higher temperature of the OT-1 TCR for OVA/Kb;
MHC complexes. this would result in a higher response at 37C as the
In a recent report, the kinetics of the soluble, mouse concentration of injected TCR was not enough to satu-
TCR OT-1 binding to OVA/Kb at 37C, but not at 25C, rate the sensor surface at 25C. Enhancement of affinity
deviated from simple 1:1 binding (Alam et al., 1999). with temperature is thermodynamically possible, and
These deviations were consistent with a TCR “dimeriza- there are examples of TCR-peptide/MHC interactions
tion” model, in which a secondTCR binds to aTCR/ that behave in this manner (Schlueter et al., 1996). These
peptide/MHC complex. A second experiment was used alternative interpretations are straightforward and easily
to support this interpretation, where under steady state testable. However, even if they are incorrect, it is clear
conditions, the binding response at 37C was close to that the two systems we have studied here, i.e., the
twice that observed at 25C. Upon performing these soluble ectodomains of A6 TCR interacting with Tax-
experiments with the A6 TCR binding to Tax/HLA-A2 based peptides presented by HLA-A2 and the HA1.7
and Tax-P6EtG/HLA-A2, we likewise observed altered TCR with the HA peptide presented by HLA-DR4,
binding kinetics at 37C similar to those observed with show no tendency to oligomerize in solution.
the OT-1 TCR (Alam et al., 1999). However, the altered An important limitation to all solution studies of what
kinetics we observed were shown to arise from interac- are normally integral membrane proteins is that restric-
tions with the Biacore sensor surface: when controlling tion in a membrane increases local concentrations and
for injections over a mock surface, the binding kinetics reduces the entropic cost of a binding reaction. These
were adequately described by a simple 1:1 kinetic mech- effects can significantly enhance binding affinities rela-
anism. Our experiments are consistent with other TCR- tive to their solution values (Grasberger et al., 1986)
(these points have been addressed qualitatively in thepeptide/MHC binding experiments performed at 37C in
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concept of “two-dimensional affinity;” Shaw and Dustin, that relative to the wild-type peptide, at 25C Tax-P6EtG
1997). Because our experiments, and those reported results in slightly weaker A6 TCR binding and a shorter
earlier, are in solution using soluble ectodomains of half-life of the TCR/peptide/MHC complex (Baker et al.,
TCR and peptide/MHC, it is thus possible thatTCR/ 2000b). These measurements are confirmed here; fur-
peptide/MHC oligomerization occurs to some extent on thermore, the same trend is observed at 37C. As we
cell membranes, yet we have been unable to detect it concluded in a previous report, for this ligand there is
due to a very weak solution affinity. Indeed, if we assume no correlation of cytotoxic potency with TCR affinity or
that the majority of the oligomers detected in the 2B4/ half-life of the TCR/peptide/MHC complex. This raises
MCC/Ek light scattering experiments (Reich et al., 1997) the possibility that membrane-bound TCR complexes
are dimers of TCR/peptide/MHC complexes and that may have altered binding properties that are not per-
these represent a conservative estimate of only 1% of fectly replicated by the isolated ectodomains of TCR
the total protein concentration, then thermodynamic molecules in solution (Baker et al., 2000b). This provides
modeling indicates a dimerization KD of only 700 M added impetus for studying fully assembled TCR inter-
is required (at a total protein concentration of 114 M acting with peptide/MHC in their native, membrane-
using a KD of 65 M for the TCR-peptide/MHC interac- bound state.
tion). For the A6 TCR complex, we would not have de-
tected such a weak affinity with analytical ultracentrifu- Experimental Procedures
gation, and it approaches our estimated centrifugation
limit for the HA1.7 complex. However, although it is less Proteins
Ectodomains of HLA-A2 and the A6 TCR were refolded from E.quantitative than analytical ultracentrifugation, sensitiv-
coli inclusion bodies as previously described (Garboczi et al., 1992,ity is much higher in the light scattering experiments.
1996b). Peptides were synthesized by Commonwealth Biotechnolo-Due to the much stronger TCR–peptide/MHC affini-
gies Inc. (Richmond, VA) and HPLC purified to  95% purity. The
ties of the systems we have studied here, the dimeriza- A6 TCR used contains the  and  chains up to and including the
tion KDs necessary to produce 1% dimers are much cysteines encoding the interchain disulfide bond, followed by a
weaker than in the 2B4 TCR system. With the A6/Tax/ linker (GSTTAPS) and a heterodimeric coiled-coil (O’Shea et al.,
1993) to stabilize the heterodimer during refolding and analysis. TheHLA-A2 complex, at a total protein concentration of 100
HA1.7/HA/HLA-DR4 complex was prepared and purified as pre-M, a dimerization KD of only 3.5 mM would be required
viously described (Hennecke et al., 2000). In brief, the HA1.7 TCRto reach a 1% population of dimers. With the HA1.7/
was refolded from E. coli inclusion bodies and HLA-DR4 purifiedTax/HLA-A2 complex at 77 M, reaching 1% dimers
from Schneider cells. The HA1.7/HA/DR4 complex was assembled
requires a very weak dimerization KD of only 5 mM. If with the aid of HLA-DM. The HA1.7 TCR used contains the  and
the percentage of dimers in the murine light scattering  chains up to 3 amino acids after the interchain disulfide. Extinction
study is less than 1%, or if the species are not dimers coefficients at 280 nm were 95,839 M1 cm1 for peptide/HLA-A2,
84,503 M1 cm1 for the A6 TCR, and 135,040 M1 cm1 for thebut oligomers of higher molecularity, then the necessary
HA1.7/HA/HLA-DR4 complex.affinities become even weaker. Thus, even though oligo-
merization on membrane surfaces remains a possibility,
Surface Plasmon Resonanceour measurements place very weak limits on the corre-
Biacore measurements were performed using a Biacore 2000 (Bia-sponding solution affinities.
core, Uppsala, Sweden). Peptide/MHC was attached to a CM5 sen-In conclusion, the differences between our current
sor chip using amine coupling. In a typical experiment, Fc 1 and 2results and those reported earlier (Alam et al., 1999;
were coupled to different densities and Fc 3 designated as a mock
Reich et al., 1997) raise questions about the generality flowcell in which injection of peptide/MHC was excluded during
of studying, by solution experiments on soluble ectodo- coupling. Data were obtained using the four cell multichannel mode.
mains, TCR oligomerization and its role in T cell signal- The instrument was normalized with glycerol after temperature
changes as recommended by the manufacturer. Buffer was 10 mMing. At a minimum, the differences question whether
HEPES, 150 mM NaCl, 3 mM EDTA, and 0.005% polysorbate-20there is convincing data from ectodomain experiments
(pH 7.4). Data manipulation and fitting were performed with Biaeva-that oligomerization is a general property of TCR/
luation 3.0 (Biacore, Inc., Uppsala, Sweden).peptide/MHC complexes at 25C or 37C. This is espe-
Equilibrium experiments were performed by injecting 23 l of
cially so when one considers arguments against oligo- MHC/peptide at a flow of 5 L/min. Steady state responses were
merization based upon variations in TCR binding orien- determined by averaging the signal over the final 15 s of the injection
tations and the low concentration of agonist peptide/ and subtracting the response obtained from the mock surface.
Steady state equilibrium responses versus concentration of injectedMHC molecules in an antigen-presenting cell membrane
TCR were fit to a 1:1 binding model:(van der Merwe et al., 2000), as well as the fact that no
physiologically oriented TCR/peptide/MHC oligo-
RUEq 	 RUmax
(1/KD)X
1  (1/KD)X
(1)mers have been observed crystallographically. We con-
clude that although dimerization or oligomerization are
still viable models for the behavior of cell surface T cell where RUmax and KD are fitted parameters and X the concentration
receptors composed ofTCR, CD3, and polypeptides of injected TCR. The fractional component of Equation 1 gives the
assembled and anchored in the membrane, Biacore ki- fractional saturation of the sensor surface. All injections were re-
peated twice. Errors in KD and RUmax are fitting errors at one standardnetic and saturation binding experiments, light scatter-
deviation.ing, and analytical ultracentrifugation experiments with
For kinetic experiments, 60 l of MHC/peptide was injected at asoluble ectodomains do not provide evidence for dimer
flow of 100 L/min. Data from the mock flowcell were subtracted
or oligomer formation at 25C or 37C. from the binding data. Association and dissociation phases were
Finally, the Tax-P6EtG peptide is a stronger agonist fit to a 1:1 binding model excluding 2 s at the beginning of each
for the A6 TCR than the wild-type Tax peptide (Baker phase as indicated by the residuals in Figures 1 and 2. All injections
were repeated twice. Fitting errors at one standard deviation areet al., 2000b). Yet our previous investigations showed
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reported for kon and koff. Errors in kon/koff and t1/2 are propagated from man T-cell receptors. Cold Spring Harb. Symp. Quant. Biol. 64,
235–241.these values.
Baker, B.M., Gagnon, S.J., Biddison, W.E., and Wiley, D.C. (2000b).
Conversion of a T cell antagonist into an agonist by repairing a defectAnalytical Ultracentrifugation
Analytical ultracentrifugation was performed using a Beckman XL-A in the TCR/peptide/MHC interface. Implications for TCR signaling.
Immunity 13, 475–484.(Beckman-Coulter, Palo Alto, CA) as previously described (Baker et
al., 2000b). In brief, for analysis of the HA1.7/HA/HLA-DR4 complex, Boniface, J.J., Rabinowitz, J.D., Wulfing, C., Hampl, J., Reich, Z.,
three concentrations (3, 7, and 13 M) of the complex were centri- Altman, J.D., Kantor, R.M., Beeson, C., McConnell, H.M., and Davis,
fuged at 12,000 rpm. Concentration versus position was recorded M.M. (1998). Initiation of signal transduction through the T cell recep-
using UV absorbance at 250 nm. The datasets at each temperature tor requires the multivalent engagement of peptide/MHC ligands.
were fit globally as previously described (Baker et al., 2000b). For Immunity 9, 459–466.
determining the adequacy of a single species fit, data from both
Boniface, J.J., Reich, Z., Lyons, D.S., and Davis, M.M. (1999). Ther-temperatures were fit separately. After verifying the quality of the
modynamics of T cell receptor binding to peptide-MHC: evidencefits, data for both temperatures were fit simultaneously to determine
for a general mechanism of molecular scanning. Proc. Natl. Acad.the molecular weight of the complex using temperature-dependent
Sci. USA 96, 11446–11451.values for density and partial specific volume.
Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G.,For measuring binding of the A6 TCR to Tax/HLA-A2, three sam-
Strominger, J.L., and Wiley D.C. (1993). Three-dimensional structureples of proteins at different concentrations were used. Concentra-
of the human class II histocompatibility antigen HLA-DR1. Naturetions of TCR and peptide/MHC were nearly equimolar and ranged
364, 33–39.from 3 to 9 M. Samples were centrifuged as above, except that
data were recorded at 255 nm and the speed was 15,000 rpm. Cochran, J.R., Cameron, T.O., and Stern, L.J. (2000). The relationship
Data were analyzed globally with a 1:1 binding model as described of MHC-peptide binding and T cell activation probed using chemi-
previously (Baker et al., 2000b). Buffer conditions for all centrifuge cally defined MHC class II oligomers. Immunity 12, 241–250.
experiements were 10 mM phosphate and 150 mM NaCl (pH 7.4).
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17, 177–187.
calculated from molecular weights and fitted reference concentra-
Degano, M., Garcia, K.C., Apostolopoulos, V., Rudolph, M.G., Tey-tions.
ton, L., and Wilson, I.A. (2000). A functional hot spot for antigen
recognition in a superagonist TCR/MHC complex. Immunity 12,
Dynamic Light Scattering
251–261.
Light scattering was performed using a DynaPro-801 (Protein Solu-
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., andtions, Inc., Charlottesville, VA). Samples were centrifuged at 15,000
Wiley, D.C. (1998). Two human T cell receptors bind in a similarrpm for 15 min to remove particulates. Solution conditions were 10
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